Sensitive and quantitative one-step polymerase chain reaction using capillary electrophoresis and fluorescence detection for measuring cytokeratin 19 expression

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 59, Issue 8, 1999, Pages 635-642

  Shammas, Fuad Victor ^a   Van Eekelen, J A M ^a   Wee, L ^a   Heikkila R ^a   Osland, A ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

BCR; Breast cancer; Calibration curve; Cytokeratin 19; Fluorescent labelling; Quantitative PCR

Indexed keywords

CYTOKERATIN 19;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FLUORESCENCE; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033388742     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519950185139     Document Type: Article

References (26)

1. 1 Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 1994; 12: 475-82.
2. 2 Krüger W, Krzizanowski C, Holweg M, Stockschläder M, Kröger N, Jung R, Mross K, Jonat W, Zander AR. Reverse transcriptase/ polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 1996; 122: 679-86.
3. 3 Moscinski LC, Trudeau WL, Fields KK, Elfenbein GJ. High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol 1996; 5: 173-80.
4. 4 Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 1996; 14: 1868-76.
5. 5 Gunn J, McCall JL, Yun K, Wright PA. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab Invest 1996; 75: 611-6.
6. 6 Schoenfeld A, Kruger KH, Gomm J, Sinnett HD, Gazet J-C, Sacks N, Bender HG, Luqmani Y, Coombes RC. The detection of micrometastases in peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 1997; 33: 854-61.
7. 7 Aihara T, Noguchi S, Ishikawa O, Furukawa H, Hiratsuka M, Ohigashi H, Nakamori S, Monden M, Imaoka S. Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Int J Cancer 1997; 72: 408-11.
8. 8 Krismann M, Todt B, Schröder J, Gareis D, Müller K-M, Seeber S, Schütte J. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 1995; 13: 2769-75.
9. 9 Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995; 71: 278-81.
10. 10 Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Guiliano AE, Cote R, Hoon DSB. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998; 16: 2632-40.
11. 11 Traweek ST, Liu J, Battifora H. Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 1993; 142: 1111-8.
12. 12 López-Guerrero JA, Bolufer-Gilabert P, Sanz-Alonso M, Barragán-González E, Palau-Pérez J, de la Rubia-Comos J, Sempere-Talens A, Bonanad-Boix S. Minimal illegitimate levels of cytokeratin K19 expression in mononucleated blood cells detected by a reverse transcription PCR method (RT-PCR). Clin Chim Acta 1997; 263: 105-16.
13. 13 Novaes M, Bendit I, Garicochea B, del Giglio A. Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors. Mol Pathol 1997; 50: 209-11.
14. 14 Savtchenko ES, Schiff TA, Jiang CK, Freedberg IM, Blumenberg M. Embryonic expression of the human 40-kD keratin: evidence from a processed pseudogenc sequence. Am J Hum Genet 1988; 43: 630-7.
15. 15 Ruud P, Fodstad Ø, Hovig E. Identification of a novel cytokeratin 9 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect mctastatic tumor cells. Int J Cancer 1999; 80: 119-25.
16. 16 Slade MJ, Smith BM, Sinnnett HD, Cross NCP, Coombs RC. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 1999; 17: 870-9.
17. 17 Cross NCP, Feng L, Chase A, Bungey J, Hughes TP, Goldman JM. Competitive polymerase chain reaction to eslimatc the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 1993; 82: 1929-36.
18. 18 Spiessl B, editor. International Union Against Cancer. Illustrated guide to the TNM/pTNM classification of malignant tumours. TNM Atlas. 3rd ed. 2nd revision. Berlin: Springer Verlag, 1992.
19. 19 Cross NCP, Melo JV, Feng L, Goldman JM. An optimized multiplex polymerase chain reaction (PCR) for detection of bcr-abl fusion mRNAs in haematological disorders. Leukemia 1994; 8: 186-9.
20. 20 Bor MV, Sørensen BS, Rammer P, Nexø E. Calibrated user-friendly reverse transcriptase-PCR assay: quantitation of epidermal growth factor receptor mRNA. Clin Chem 1998; 44: 1154-60.
21. 21 Tschentscher P, Wagener C, Neumaier M. Sensitive and specific cylokeratin 18 reverse transcription-polymerase chain reaction that excludes amplification of processed pseudogenes from contaminating genomic DNA. Clin Chem 1997; 43: 2244-50.
22. 22 Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-8.
23. 23 Dostal DE, Rothblum KN, Baker KM. An improved method for absolute quantification of mRNA using multiplex polymerase chain reaction: determination of renin and angiotensin mRNA levels in various tissues. Anal Biochem 1994; 223: 239-50.
24. 24 Dassi C, Signorini S, Gerthoux P, Cazzaniga M, Brambilla P. Cytochrome P450 IBI mRNA measured in blood mononuclear cells by quantitative reverse transcriptase-PCR. Clin Chem 1998; 44: 416-21.
25. 25 Corey E, Arfman EW, Liu AY, Vessella RL. Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow. Clin Chem 1997; 43: 443-52.
26. 26 Bader BL, Jahn L, Franke WW. Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeralin 19 gene. Eur J Cell Biol 1988; 47: 300-19.